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Transcription-factor Runx1 orchestrates the injury response of many cardiac cell-types 
balancing collagen and fibrin deposition and clearance as well as affecting myocyte 
proliferation and survival in zebrafish. 
 
Abstract  
Runx1 is a transcription factor that plays a key role in determining the proliferative and 
differential state of multiple cell types, during both development and adulthood. Here, we 
report how Runx1 is specifically upregulated at the injury site during zebrafish heart 
regeneration, and that absence of runx1 results in increased myocardial survival and 
proliferation and overall heart regeneration, accompanied by decreased fibrosis. Using single 
cell sequencing, we found that the wild-type injury site consists of Runx1-positive endocardial 
cells and thrombocytes that induce expression of smooth muscle and collagen genes. Both 
these populations cannot be identified in runx1 mutant wounds that contain less collagen and 
fibrin. The reduction in fibrin in the mutant is further explained by reduced myofibroblast 
formation and upregulation of components of the fibrin degradation pathway, including 
plasminogen receptor Annexin 2A as well as downregulation of plasminogen activator inhibitor 
serpine1 in myocardium and endocardium, resulting in increased levels of Plasminogen. Our 
findings suggest that Runx1 controls the regenerative response of multiple cardiac cell-types 








Heart regeneration potential varies considerably between species as well as with age. While 
zebrafish and neonatal mouse hearts can replace dead or lost cardiomyocytes rapidly with 
new heart muscle (Poss, Wilson and Keating, 2002; Jopling et al., 2010; Porrello et al., 2011; 
Wang et al., 2011), medaka (Ito et al., 2014; Lai et al., 2017), cave fish (Stockdale et al., 2018), 
as well as adult mice and human hearts (Senyo et al., 2013) show only poor repair. Numerous 
studies are, therefore, looking into the underlying principles and mechanisms that promote, or 
prevent, effective cardiac regeneration to establish a basis for therapeutic intervention 
(González-Rosa, Burns and Burns, 2017). In models of successful regeneration, remaining 
cardiomyocytes have been shown to proliferate and replace the fibrotic tissue with new heart 
muscle (Jopling et al., 2010; Kikuchi et al., 2010; Chablais et al., 2011; González-Rosa et al., 
2011). This is dependent on a fine balance of interaction with other cell-types, including the 
epicardium and endocardium (González-Rosa, Burns and Burns, 2017; Cao and Poss, 2018). 
Due to the complexity of this interaction, we still lack a clear understanding of how the fibrotic 
tissue can be broken down and replaced by proliferating myocardial cells. Here, we report a 
role for Runx1 in regulating the delicate balance between collagen and fibrin degradation and 
myocardial regeneration.  
 Runx transcription factors, which hetero-dimerise with core binding factor β (CBFβ), 
are transcription factors that can function as activators as well as repressors and, as such, are 
important regulators of lineage-specific cell fate. Runx1 (also known as acute myeloid 
leukaemia 1 protein (AML1) or core-binding factor subunit alpha-2 (CBFA2)) is a master 
transcription factor for determining the proliferative and differential state of multiple cell-types, 
during both development and adulthood. Runx1 is most studied for its role in endothelial-to-
haematopoietic transition during haematopoiesis in development (Lacaud et al., 2002; Chen 
et al., 2009; Lancrin et al., 2009; Boisset et al., 2010; Kissa and Herbomel, 2010; Lam et al., 
2010) and as a well-known fusion oncogene (Silva et al., 2003; Blyth, Cameron and Neil, 
2005). Relatively little is known about the role of Runx1 in skeletal and heart muscle. It has 
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been shown that Runx1 is important in skeletal muscle stem cell (SC) proliferation and its 
levels can affect the proliferative timing and thus the regenerative capacity of skeletal muscle 
cells (Umansky et al., 2015). In the heart, Runx1 is expressed in neonatal mouse 
cardiomyocytes and is upregulated in zebrafish, adult mouse, rat and human cardiomyocytes 
after injury (Gattenlöhner et al., 2003; Kubin et al., 2011; Eulalio et al., 2012; Górnikiewicz et 
al., 2016; Goldman et al., 2017). Conditional Runx1 deficiency in mouse cardiomyocytes has 
been demonstrated to protect the mouse against the negative consequences of cardiac 
remodelling after myocardial infarction (McCarroll et al., 2018). Although no changes in injury 
size were found between myocardial conditional Runx1 knock-out and control mice, the 
remaining cardiomyocytes displayed improved calcium handling, accompanied by improved 
wall thickness and contractile function compared to wild-type (McCarroll et al., 2018). 
However, as the knockout was cardiomyocyte specific, the involvement of other cardiac cell-
types was not investigated. In contrast to mouse, where constitutive Runx1 deletion is 
embryonically lethal, zebrafish runx1W84X mutants (Jin et al., 2012) are homozygote viable 
adults, allowing us to investigate the role of runx1 loss of function during zebrafish heart repair 
down to the single cell level.  
We show that Runx1 has important roles in the response of various cell-types to injury, 
including thrombocytes, the epicardium, endocardium and myocardium. Thrombocytes are 
the fish equivalent of platelets and important for blood clotting, with the difference that these 
are nucleated cells (Jagadeeswaran et al., 1999). We demonstrate that the removal of runx1 
leads to several unique cell-type specific responses within the heart, affecting cardiomyocyte 
proliferation and initial survival, deposition and degradation of fibrotic tissue/extracellular 
matrix at the wound site and overall heart regeneration.  The cellular composition of the 
wounded ventricle is altered between wild-types and runx1 mutants, with most noticeably the 
lack of thrombocytes and endocardial cells that express smooth muscle and collagen genes 
in the mutant.  Additionally, the epicardium shows a reduction in the level of smooth muscle 
and collagen genes in the runx1 mutant, on top of which there is a strong reduction in the 
number of cell clustering as myofibroblasts in runx1 mutants. Additionally, there is a strong 
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upregulation of components of the fibrin degradation pathway, including the Annexin A2 
complex. Taken together, our analysis suggests that heart regeneration is facilitated in the 
absence of runx1 and identifies Runx1 inhibition as a potential therapeutic target to improve 
cardiac repair. 







Runx1 becomes widely expressed in zebrafish hearts after injury. 
To evaluate runx1 expression in the adult heart we induced cryo-injury using a liquid nitrogen 
cooled probe in the Tg(BAC-runx1P2:Citrine) zebrafish line, in which cytoplasmic Citrine 
fluorescence is placed under the control of the runx1 P2 promotor (Bonkhofer et al., 2019). 
While several other transgenic runx1 reporter zebrafish lines have been published, these were 
either enhancer lines (Goldman et al., 2017) or the Tg(runx1P2:EGFP) line with a short 
promoter sequence displaying ectopic expression during development (Yi et al., 2009; Lam et 
al., 2010), prompting us to utilize a line with a larger regulatory region (Bonkhofer et al., 2019). 
The P2 promoter is the main one of 2 runx1 promoter regions known to drive expression in 
definitive hematopoietic stem cells (HSCs) in the dorsal aorta during development (Lam et al., 
2010), however, its expression in the adult heart is unknown. In the uninjured heart, Runx1-
Citrine expression was sparse but present in a small number of cells spread throughout the 
heart, mostly blood cells (Fig. 1a-a’). However, after injury, expression became much more 
widespread: one day post cryo-injury (dpci), a large collection of bright Citrine positive cells 
was present in the injury site (Fig. 1b-b’), indicating the presence of Citrine positive blood cells 
in the wound. In addition to the blood cells, other cell populations started to express Citrine, 
including cells within the epicardium all around the heart (arrowheads, Fig. 1b). Additionally, 
weak expression of Citrine was observed in cardiomyocytes bordering the injury site (Fig. 1b’-
b”, insert). Three days after injury, Citrine expression in these cell-types was even more 
pronounced, especially within the endocardium specifically near the injury site (arrowheads, 
Fig. 1c-c”). Moreover, at this time-point, myocardial cells surrounding the injury site strongly 
expressed Citrine as shown by overlapping expression of Citrine with myocardial marker 
MF20 (Fig. 1c-c”, insert). This pattern was maintained at 7dpci, but started to taper-off around 
14dpci (Supp Fig. 1a-a”, Fig. 1c-d”). Even in sham operated hearts, in which the ventricle was 
only exposed to a room-temperature probe, Citrine expression was upregulated in both the 
epicardium (arrowheads) and myocardium, but not endocardium (Supp Fig. 1b-b”). To verify 
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the cell-type specific expression of Citrine, we confirmed overlapping expression with different 
cell-type specific markers. The bright blood cell population present in the wound at 1dpci was 
also highly positive for itga2b, which is a marker for nucleated thrombocytes (arrowheads, Fig. 
1e-e’) (Albert and Christopher N, 2013). Additionally, we found Citrine overlapping with 
leukocyte marker LyC, endothelial/ endocardial marker ERG1 and epicardial/fibroblast marker 
tcf21 (Supp Fig. 1c-e) at 3dpci. As runx1 expression was analysed by visualisation of a 
transgene, we also checked if transgene expression followed the same pattern as 
endogenous runx1 RNA using RNA-scope in situ hybridisation (Wang et al., 2012). Runx1 
RNA and Citrine expression showed clear overlapping expression patterns, with RNA present 
in the Citrine positive epicardium, myocardium and endocardium (Supp Fig. 2a-c) after injury. 
Runx1 RNA was not or very low expressed in the Citrine-negative myocardium of the rest of 
the ventricle (Supp Fig. 2b-c, asterisks). To summarise, runx1 expression becomes strongly 
upregulated in several cell populations of the heart after injury, in the myocardium, 
endocardium and epicardium surrounding the wound area. This upregulation of Runx1-Citrine 
after cryo-injury suggests a role for runx1 in multiple cell-types during heart regeneration.  
 
Faster compact wall regeneration in runx1 mutants compared to wild-type zebrafish 
Based on the observed expression of Runx1 after injury, we questioned if heart regeneration 
is affected in absence of runx1. We used the adult homozygote viable global runx1W84X/W84X 
mutant, which has a premature STOP codon truncation mutation, leading to an almost 
complete loss of the Runt domain and loss of function (Jin et al., 2009; Sood et al., 2010). 
After performing cryo-injury on runx1 wild-type and mutant fish we isolated the hearts at 5 
different time-points, from 3 to 70 days post injury. Acid Fuchsin Orange G staining (AFOG, 
labelling collagen in blue, fibrin in bright red and all other cells including the myocardium/blood 
cells in orange), showed a clear difference between wild-type and runx1 mutant hearts (Fig. 
2a-k). At 3dpci, the injury site was clearly visible in both fish, but the wild-type hearts showed 
a much more extensive deposition of bright red fibrin compared to the mutants (Fig. 2a). As 
well as less fibrin deposition, we also observed reduced collagen (blue) deposition at 7dpci in 
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the mutants (Fig. 2b, h-k). While the wild-type wound consisted on average of 39.2% fibrin 
(red) blood clot and 14.3% collagen (blue), runx1 mutant hearts had around 22.7% fibrin (red) 
and 2.4% collagen (blue) labelling. Despite these differences in wound composition, 
comparison of the wound size did not show any significant differences between the wild-type 
and mutant hearts at 3 and 7dpci (Fig. 2a-b, f-g). However, at 14dpci, there was a significantly 
stronger decrease in open wound length in the mutant compared to the controls, indicating a 
faster resolution of the lesion (Fig. 2c, f-g). At 30dpci both mutants and controls had closed 
the compact myocardial wall over the wound indicating good overall repair progress, but the 
remaining internal lesion was less pronounced in the mutants, with blue collagen mainly 
present in between the regenerated trabeculae (Fig. 2d). The difference was still visible at 
70dpci, with trace amounts of blue collagen label present in the mutants. These data show 
that the runx1 mutants have a significantly larger area of their compact wall closed at 14dpci 
compared to wild-types and deposit a different fibrotic tissue/ extracellular matrix after heart 
injury compared to wild-types.  
  
Increased myocardial proliferation and myocardial protection against cryo-injury in the 
runx1 mutant 
As we found that Runx1-Citrine expression was activated in cardiomyocytes that were in direct 
contact with the wound (Fig. 1) and these border-zone cardiomyocytes are known to be highly 
proliferative and to contribute new cardiomyocytes to the wound (Jopling et al., 2010), we 
wanted to investigate if the more rapidly healing runx1 mutants show increased myocardial 
proliferation. To test this, proliferating cells were labelled on sections with Proliferating Cell 
Nuclear Antigen (PCNA) and myocardial nuclei with Mef2. Myocardial proliferation was 
significantly increased near the wound in mutants compared to the wild-types at all time-points 
analysed (Fig. 3b). Thus, Runx1 expression in the wound border zone cardiomyocytes 
appears to inhibit myocardial proliferation. Additionally, in the runx1 mutant wound, we also 
observed a large number of myocardial cells surviving after cryo-injury, most notably at 3dpci, 
which were absent in wild type injured hearts and independent of initial wound size (Fig. 3c-
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d). These surviving myocardial cells had strongly reduced in numbers at 7dpci in the mutant, 
suggesting that this protection is likely temporary and that these cells do not survive long-term 
(Fig. 3c-d). They did not express Runx1-Citrine and had lost their normal myofibril/sarcomere 
structure (Fig. 3e). This initial protection of cardiomyocytes against injury resembles the 
cardio-protective effect described in mice, which was found to be linked to an improved 
calcium uptake of the sarcoplasmic reticulum (McCarroll et al., 2018). To establish if the 
increase in myocardial proliferation and survival are linked, we also performed resection injury 
during which a small portion of the ventricular apex was removed using fine scissors, excluding 
any myocardial survival within the wound. After resection injury, both myocardial proliferation 
and compact wall regeneration were not significantly different between the mutants and wild-
types (Supp Fig 3a-d), indeed suggesting that there could be a link, even though intuitively 
better survival implies less demand for proliferation. Taken together, these findings reveal 
pleiotropic roles for Runx1 in reducing cardiomyocyte proliferation and survival following heart 
injury. 
 
Significant increase in Runx1-Citrine positive endocardial cells after injury 
Since we also observed strong expression of Runx1-Citrine in the endocardium, which plays 
crucial roles during regeneration (González-Rosa, Burns and Burns, 2017; Münch et al., 2017; 
Sánchez-Iranzo et al., 2018), we next analysed the runx1 expressing endocardium in more 
detail (Fig. 4a-f). We crossed the Tg(BAC-runx1P2:Citrine) with the Tg(kdrl:Hsa.HRAS-
mCherry) line (Chi et al., 2008), which in combination label Runx1-Citrine 
endothelial/endocardial cells with membrane mCherry fluorescence, and initially observed 
very few Citrine-mCherry double positive cells in intact unopened or sham-operated hearts 
(Fig. 4e). At 1dpci, we observed a significant increase in mCherry positive cells in the wound 
area with a flat endocardial cell morphology and dim Citrine expression compared to the bright 
Citrine-positive blood cells (Fig. 4a’, e). Double positive cells were most clearly visible at 3dpci 
(Fig. 4b-b’, e), with a rounder cell morphology, while throughout the remaining intact ventricle 
away from the wound, only few cells were observed at all stages analysed (ventricle, Fig. 4c-
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c’, e). This Citrine/mCherry double positive population was still highly present at 7dpci, but 
decreased towards baseline levels at 14dpci (Fig. 4d-e). The known functions of Runx1 
(Lacaud et al., 2002; Chen et al., 2009; Lancrin et al., 2009; Boisset et al., 2010; Kissa and 
Herbomel, 2010; Lam et al., 2010), combined with its extensive expression pattern in the 
endocardium, suggests a novel role for runx1 in the endocardium during regeneration. 
   
Single cell sequencing identifies subpopulations of runx1 expressing cells after injury 
To further investigate the function of Runx1 in all runx1 expressing cell types after injury, with 
a focus on the endocardium/endothelium, we performed single cell sequencing using the 10x 
Genomics platform. The runx1W84X/W84X mutant line was crossed into the Tg(BAC-runx1P2: 
Citrine;kdrl:Hsa.HRAS-mCherry) background and confirmed for preserved BAC-
Runx1P2:Citrine expression (Supp Fig. 4a). Citrine expression was overall similar to that in 
the wild-type heart, including expression in endocardial cells. However, we observed a 
reduction in the number of Citrine and mCherry double positive cells in the mutant wound (Fig. 
4f-g). The ventricles of runx1 wildtype uninjured, runx1 wild-type 3dpci and runx1 mutant 3dpci 
Tg(BAC-runx1P2:Citrine;kdrl:Hsa.HRAS-mCherry) fish were dissociated and FACS sorted 
(Fig. 5a). FACS sorting for Citrine and mCherry, we found a 4.5-fold increase in double positive 
cells in wild-type 3dpci hearts compared to wild-type uninjured hearts, confirming our image-
based cell counts (Supp Fig. 4b, Fig. 4e). Mutant hearts had only a third of the amount of 
double positive cells after injury compared to wild-types (Supp Fig. 4b). Before sequencing, 
we excluded negative cells and combined all single positive and double positive cells, while 
enriching for the double positive population which might otherwise have been missed during 
single cell analysis, due to their low numbers. Sequencing and subsequent clustering of all 
cells combined led to the identification of 27 cell clusters (C) that comprised all the expected 
cell populations, including endocardial/ endothelial cells, myocardial cells, epicardial cells, 
myofibroblasts, thrombocytes and different leukocyte populations (Fig. 5b-c, supp Fig. 5a). 
Kdrl/mcherry mRNA positive cells were mainly present in a large group of closely related cell 
clusters (C0-6), whereas runx1/citrine mRNA-positive cells were as expected present in all 
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clusters, and double positive cells largely grouped in the main kdrl/mcherry group (Fig. 5d). In 
the uninjured heart, endocardial/endothelial cells grouped into 3 main different clusters 
(C1,3,4), indicating a degree of heterogeneity within these cell populations (Fig. 5e). After 
injury in both wild-type and runx1 mutant hearts, 2 large additional endocardial/endothelial cell 
populations appeared (C0,2) while C3 was reduced in number (arrowheads, Fig. 5e). These 
injury-specific endocardial populations were highly positive for serpine1 expression (Supp Fig. 
5b), indicating that this population is largely similar to the previously identified highly mobile 
serpine1-positive endocardial population (Münch et al., 2017), which was confirmed on 
sections (Supp Fig. 5c-c’, arrowheads). Although citrine-positive populations of neutrophils 
and macrophages were present in both the mutant and wild-type after injury (C13,15), we 
observed differences in other blood cell populations and most notably, mutant hearts lacked 
an obvious cluster of mature thrombocytes and monocytes (C 24-25 and C16, Fig. 5b-e). In 
contrast, other blood cell clusters unique to the mutant were present (C19, 22, 23), and 
characterised by highly expressed genes such as gata2b or myb (Supp Fig. 5d). Analysis of 
wild-type and mutant tissue sections confirmed the unique presence of these abnormal blood 
cell populations in the mutant, resulting in an altered leukocyte profile in the wound after injury 
(Supp. Fig. 5e-h’). While nonsense medicated decay (El-brolosy et al., 2019) could be a 
possibility in the runx1 mutant, we did not find upregulation of other compensating runx genes 
(runx2a, 2b and 3). These results show on a single cell basis how Runx1 becomes activated 
after injury with specific cell composition differences between the mutant and wild type hearts. 
 
Runx1-positive endocardial cells express smooth muscle genes  
Within the individual runx1-citrine expressing cell groups, we focussed next on the 
endocardial/endothelial cells in the wild-type uninjured and wild-type 3dpci hearts. 
Citrine/mcherry double positive endocardial cells showed a highly injury specific upregulation 
of collagens, for example collagen 1a1b (Fig. 6a). Upregulation of collagens in the wound 
endocardium has been observed before (Münch et al., 2017; Sánchez-Iranzo et al., 2018), but 
has not previously been analysed using single cell transcriptomics. Clustering of the 
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citrine/mcherry double positive cells showed 2 clusters (C4 and C5) appearing after injury, 
with upregulation of genes involved in extracellular matrix formation as well as endothelial-to-
mesenchymal transformation (EMT, snai1a/b, snai2, zeb2b) (Fig. 6b-c, Supp Fig. 6a). 
Interestingly, the endocardial cells of cluster 4 can be identified by specifically upregulated 
smooth muscle genes, with high expression of myh11a, myl6 and myl9a/b. Tagln (sm22a) 
was expressed in both clusters 4 and 5, but strongest in cluster 4 (Fig. 6c-d). While smooth 
muscle gene expression has been suggested before in the border zone endocardium (Wu et 
al., 2016), we were able to confirm this expression of smooth muscle gene Myh11 in 
endocardial cells on sections (arrowheads Fig. 6e-f, Supp Fig. 6b). These data combined 
suggests that the runx1-positive endocardium is a heterogeneous cell population, with subsets 
of cells starting to express collagens, EMT genes and/or smooth muscle genes after injury. 
While the expression of EMT genes suggests that these endocardial cells could become 
mesenchymal, recent lineage tracing of the endocardium did not point to contribution of the 
endocardium to collagen-forming cells (Sánchez-Iranzo et al., 2018). As the combination of 
high collagen and smooth muscle gene expression is considered a hallmark of myofibroblasts, 
we investigated this in more detail and expanded our analysis to the runx1 mutants. 
 
Smooth muscle genes are expressed in the endocardium and thrombocytes, but both 
these cell clusters are absent in the runx1 mutant 
We first wanted to see if the lower number of citrine/mcherry double positive cells in the mutant 
obtained a similar smooth muscle profile as the injured wild-type and included the runx1 
mutant to our analysis of double positive cells of the single cell data. While cluster 5 cells were 
present, the smooth muscle gene expressing endocardial cluster 4 was completely absent in 
the runx1 mutant (arrowheads, Fig. 7a-b), as were the cells most strongly expressing myh11a 
and tagln (Fig. 7b). Analysis of Myh11 expression in the wound confirmed that much fewer 
Myh11 positive cells were found in the mutant heart sections, however, the strongly reduced 
area of cells expressing Myh11 in the mutant (Fig. 7c-d) was too large to be attributed 
exclusively to endocardial cells. While analysing endocardial Myh11 presence via antibody 
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staining, we also noticed Myh11 presence in circulating blood cells in wild-type hearts 
(arrowheads, Fig. 7e-e’). Myh11 is often considered a marker for smooth muscle and 
myofibroblasts, but in addition to being present in endocardial cells, Myh11 staining also 
clearly overlapped with strong itga2b expressing cells, identifying these cells as thrombocytes 
(Fig. 7e-e’). The single cell data in turn confirmed that the itga2b-positive thrombocyte 
populations highly express myh11a (Fig. 5b-c, Fig. 7f-g) and we confirmed the accumulation 
of Myh11/itga2b positive thrombocytes in the wound area after injury (arrowheads, Fig. 8a). 
Also in line with the single cell data, we found that the Myh11-positive thrombocyte population 
was largely absent in the mutant (Fig. 8a-b’). This means that both smooth muscle gene-
expressing cell types, the Myh11-positive endocardium and thrombocytes, are behaving 
differently in the mutant. It raises the questions of what happens to these cells over time in the 
wild-type situation and how that relates to the observed differences in fibrin and collagen 
between the wild-types and mutants in the AFOG stained sections (Fig. 2). At 14dpci, we 
found that Myh11 is still largely present in the endocardium and thrombocytes in wild-types 
(arrowheads, Fig. 8c-d’). This double identity could mean that part of the fibrosis forming cells 
in fish do not completely differentiate into full myofibroblasts, but remain endocardial or 
thrombocyte in nature. We cannot exclude that at least some cells lose the expression of the 
endothelial and thrombocyte markers, but at 14dpci, when the wound size is already reducing, 
a large number of Myh11-positive cells on the luminal side of the wound still have a 
thrombocyte or endocardial profile. Interestingly, most collagen (blue) deposition in the wound 
seen in the AFOG staining (Fig. 2b-c) was observed near the location of the Myh11 expressing 
endocardial cells and thrombocytes, and to much lesser extend near the epicardium (Fig. 2b-
c, 8a). The strong reduction of both the blue AFOG staining and Myh11-positive cells in the 
mutant suggests, therefore, that a large proportion of this collagen could be deposited by the 
Myh11-positive endocardial cells and thrombocytes, instead of myofibroblasts. A reduction of 
these cells could, therefore, potentially explain the different wound composition as well as the 
improved resolution of fibrotic tissue during heart regeneration in the runx1 mutant. This is a 
novel and surprising finding, as the epicardium is considered the main source of 
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myofibroblasts and collagen deposition in the heart (Kikuchi et al., 2011; González-Rosa, 
Peralta and Mercader, 2012; Sánchez-Iranzo et al., 2018). 
 
Changes in Runx1-Citrine positive epicardial cells after injury 
As the epicardium has been shown to contribute myofibroblasts to the wound in zebrafish 
(González-Rosa, Peralta and Mercader, 2012; Sánchez-Iranzo et al., 2018), and we observed 
activation of Runx1-Citrine in the epicardium, we next compared the epicardial cluster to the 
myofibroblast/smooth muscle cluster (C8 and C10, Fig. 5b-c, 9a). Cluster 10 is a distinct 
population of cells specifically appearing after injury that, in addition to the endocardial and 
thrombocyte populations, strongly expresses both myh11a as well as collagens (Fig. 9b). The 
high levels of expression of smooth muscle genes as well as collagens, suggest that these 
cells are mainly myofibroblasts, but may also include smooth muscle cells. In the uninjured 
wild type heart, only a few cells of both populations were positive for Runx1-Citrine (Fig.1a, 
9a), but there was a heart-wide activation of Runx1 in the epicardium and myofibroblasts after 
injury (Fig. 1b-c, 5e, 9a). The epicardial cell cluster expressed a combination of genes known 
to be epicardial specific, including tcf21 and wt1a/b, while myh11a expression was specific for 
the myofibroblast cluster. However, other myofibroblast genes, such as tagln and collagens, 
were present in both the epicardial and myofibroblast clusters (Fig. 9b). Staining on sections 
confirmed the absence of Myh11, but presence of Tagln in the epicardium (Fig. 9c). In the 
runx1 mutant, similar to the reduction in other myh11a expressing cells types, the number of 
myofibroblasts was much lower. In contrast, the epicardial cell population was slightly larger 
in the mutant (Fig. 9d), but had reduced levels of both collagen and smooth muscle genes 
(Fig. 9e). The location of the myofibroblast C10 cluster on the UMAP plot in Fig. 5b as well as 
the presence of tbx18 and tcf21 in this cluster suggest that these cells are closer related to 
the epicardial cluster than to the myh11a expressing endocardial cells. The presence of 
myofibroblast genes in the epicardium and vice versa might reflect the lineage transition from 
epicardial cells to myofibroblasts that has been shown before (González-Rosa, Peralta and 
Mercader, 2012). Both the C8 and C10 cluster express genes involved in EMT, which are 
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reduced in the mutant, suggesting possibly reduced EMT from the epicardium. Analysis on 
sections confirmed that Myh11-positive cells close to the epicardium were less abundant in 
the mutant compared to the wild-type (arrowheads, Fig. 9f-g). The strong reduction in 
myofibroblasts in addition to the absence of smooth muscle gene expressing endocardium 
and thrombocytes, further explains the difference in wound composition between the mutant 
and wild-type.  
 
Upregulation of Plasminogen receptor Annexin a2 in the runx1 mutant myocardium and 
endocardium 
In addition to smooth muscle genes, our single cell sequencing data showed upregulation of 
a number of genes involved in fibrinolysis in the endocardium after injury, including anxa2a 
and s100a10b (Fig. 10a). Anxa2 is a calcium-dependent phospholipid-binding protein that 
forms the Annexin A2 hetero-tetramer protein complex together with S100A10 (Madureira et 
al., 2011) and is an important Plasminogen receptor. Plasminogen is required for dissolving 
fibrin blood clots and acts as an important protease in tissue remodelling and repair. The 
Annexin A2 complex was specifically upregulated after injury in the wild-type runx1-citrine-
positive endocardium, but much stronger in the runx1-citrine-positive runx1 mutant 
endocardium (Fig. 10a). In contrast, serpine1 (also called Plasminogen Activator Inhibitor 1), 
an inhibitor of fibrinolysis, was much stronger upregulated in the injured wild-type endocardium 
than in the runx1 mutant (Fig. 10a), suggesting increased fibrinolysis in the runx1 mutant 
underlies the reduced amount of fibrin in the wound (Fig. 2). Interestingly, thbs1b 
(Thrombospondin 1b), which is required for thrombocyte and fibrin aggregation, is specifically 
expressed in the smooth muscle-expressing endothelial population that is missing in the 
mutant, as a potential link to the absence of thrombocytes and fibrin aggregates in the mutant 
(arrowheads, Fig. 10b).  
In addition to its expression in the endocardium, we also found calcium-dependent 
anxa2a to be the highest upregulated gene in the myocardium in the runx1 mutant, again 
suggesting an increased expression of the Plasminogen receptor in the mutant compared to 
16 
 
wild-types (Fig. 10c). In a previous study, cardiomyocyte specific knock-out of Runx1 in the 
mouse showed increased sarcoplasmic reticulum calcium content and sarcoplasmic 
reticulum–mediated calcium release in the myocardium after injury (McCarroll et al., 2018). 
Correspondingly, we found increased expression of calcium-responsive genes in the citrine-
positive myocardium of our zebrafish runx1 mutant after injury; including Calmodulins calm1b, 
calm2b and calm3a (Fig. 10c, (cluster C11 in Fig. 5b-c). We also observed increased 
expression of genes important for sarcomere formation in the Citrine-positive myocardium in 
the wild-type hearts (Fig. 10c). Border zone cardiomyocytes have been shown to undergo de-
differentiation with loss of sarcomere structures and re-expression of embryonic myosin, 
followed by re-differentiation and sarcomere formation (Jopling et al., 2010; Sallin et al., 2015; 
Wu et al., 2016). In line with this, we also found upregulation of embryonic myosin myh7 in the 
wild-type Citrine-positive cardiomyocytes (Fig. 10c).  The combination of embryonic and 
mature myosin RNA expression points to these cells acquiring a more embryonic state, while 
undergoing the de- and re-differentiation process during proliferation. In the runx1 mutant, 
however, this upregulation of both embryonic and mature sarcomere genes was reduced at 
the mRNA level (Fig. 10c). This could potentially be explained by the much higher rate of 
proliferation in the runx1 mutant, resulting in a prolonged de-differentiation state before 
specific activation of myosin/sarcomere gene expression or alternatively, the presence of 
surviving cardiomyocytes in this cluster. The wound border cardiomyocytes in the mutant 
show a less organised structure and include surviving cells that have lost their sarcomere 
structure (Fig. 10d-e’’). 
We next confirmed the expression of both anxa2a and serpine1 at 3dpci, which 
showed that anxa2a, as well as Anxa2 protein, has a very similar expression pattern to runx1, 
however, with much stronger expression in the endocardium (white arrowheads) and 
myocardium (yellow arrowheads) in the mutant than in the wild-type (Fig. 10d-g’). Serpine1 
was indeed also expressed in the wound border myocardium and endocardium, further 
confirming the single cell data. The increase in anxa2a and s100a10b, that together convert 
Plasminogen into Plasmin to increase fibrinolysis, accompanied by the reduction in fibrinolysis 
17 
 
inhibitor serpine1, all point to substantial differences in Plasmin levels and thus fibrinolysis in 
the runx1 mutant. In concordance, Plasminogen was far more abundant in the wound in the 
mutant (Fig. 10f-g). Therefore, in addition to a lack of fibrin deposition by endocardial cells, 
thrombocytes and myofibroblasts, runx1 mutant hearts also show increased fibrinolysis that 




By interrogating Runx1 function on a single cell level in a global runx1 null mutant, we have 
exposed Runx1 as an inhibitor of heart repair on many levels. The overarching change we 
observed in different injury responsive cell-types was a strong reduction of smooth muscle 
and collagen gene expression in the mutant after injury. The expression of high levels of 
smooth muscle and collagen genes is a hallmark of myofibroblasts, but we identified both 
endocardial cells and thrombocytes to express myofibroblast-like genes after injury. The 
endocardium proximal to the wound has been described before to upregulate collagens 
(Münch et al., 2017; Sánchez-Iranzo et al., 2018) as well as smooth muscle genes such as 
tagln and myl6 (Wu et al., 2016). However, the thrombocytes that make up a large proportion 
of the wound have not been described before to express Myh11. Surprisingly, we observed 
most collagen deposition in the wound localised adjacent to the Myh11 expressing endocardial 
cells and thrombocytes, and to a much lesser extent near the epicardium, despite the fact that 
the epicardium is considered the main source of myofibroblasts and collagen deposition in the 
heart(González-Rosa, Peralta and Mercader, 2012; Sánchez-Iranzo et al., 2018). This 
suggests that while these cells retain the characteristics of endocardial cells and 
thrombocytes, they can function analogously to myofibroblasts. The double identity of these 
cells may mean that the cells responsible for the injury induced fibrosis in fish are more 
transient and less differentiated compared to fully mature myofibroblasts. This in turn may 
reflect deposition of less stable, degradable fibrotic tissue compared with the mammalian 
situation, in which myofibroblasts predominate and a scar can persist for many years after MI 
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(Turner and Porter, 2013). Runx1 mutants do not have a Myh11 expressing endocardial and 
thrombocyte population, and have fewer myofibroblasts. This alone could explain the 
significant reduction in collagen and fibrin in the wound, however, the runx1 mutant also shows 
increased expression of the Plasminogen receptor Annexin A2 as well as Plasminogen itself. 
Annexin A2 converts Plasminogen into Plasmin, the major fibrinolytic agent that breaks down 
fibrin in blood clots (Madureira et al., 2011; Christensen et al., 2018). In addition to a reduction 
in collagen and fibrin depositing cells, the increased levels of Plasminogen point to faster 
degradation of deposited fibrotic tissue, allowing improved migration of myocardial cells into 
the wound to regenerate the heart.  
 The Tg(BAC-runx1P2:Citrine) reporter line we used was made using bacterial artificial 
chromosome technology (BAC) to create a transgene that has both runx1 promoters including 
a large upstream region. The BAC contains the runx1 P1 promoter region with ~25,000 bp of 
upstream sequence and the P2 promoter region (with a ~90,000 bp large intron between P1 
and P2) and only contains exon 2b and 3, but none of the other exons further downstream 
(Bonkhofer et al., 2019). The inclusion of the very large upstream regulatory region of runx1 
likely explains the observed fluorescent transgene expression differences when compared to 
any other previously published runx1 transgenic fish lines (Jin et al 2009, Goldman et al 2017).  
Goldman et al. have identified a 103kb upstream region of runx1 that specifically drives 
expression in the zebrafish wound border myocardium after injury and termed it a 
cardiomyocyte regeneration enhancer (CREE)(Goldman et al., 2017). The expectation based 
on the results with this enhancer was that Runx1 expression in the myocardium near the 
wound is beneficial for heart regeneration. A positive role for Runx1 was also suggested by 
its upregulation in hearts treated with Oncostatin M, which has been shown to protect the heart 
after acute MI (Kubin et al., 2011), as well as in hearts that overexpress Erbb2 and show 
enhanced myocardial proliferation and regeneration (D’Uva et al., 2015). High levels of 
cardiomyocyte Runx1 expression were linked to the reduced differentiation state of 
cardiomyocytes in these models which facilitates dedifferentiation and increased proliferation 
leading to improved levels of heart repair. However, this hypothesis was solely based on 
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expression data and not functionally tested. In contrast, our findings demonstrate the opposite, 
in that loss of runx1 results in enhanced heart regeneration, by increasing myocardial 
proliferation, increasing myocardial survival, and by altering wound tissue composition as 
discussed above. This poses the question as to why Runx1 is specifically upregulated during 
both zebrafish heart regeneration and mammalian heart repair (Kubin et al., 2011; D’Uva et 
al., 2015; Goldman et al., 2017; McCarroll et al., 2018) when it seems to function to inhibit key 
regenerative processes. The answer might lie in the fact that absence of runx1 causes 
increased proliferation and upregulation of the Annexin 2a receptor, which is strongly linked 
to proliferation in cancer (Christensen et al., 2018). Runx1 might function to keep proliferation 
of cardiomyocytes, as well as other cell types, in check and prevent them from getting out of 
control during myocardial regeneration. This fits well with the observations that Runx1 acts as 
a key factor in determining the proliferative and differential state of multiple cell-types (Murthy 
et al., 2014; Umansky et al., 2015; Bao et al., 2018; Sarper et al., 2018; Zhou et al., 2018) 
alongside different functions that correlate with level of Runx1 expression (Lie-a-ling et al., 
2018; Antony-Debre et al., 2019), with higher levels shown to result in cell fate transition and 
differentiation (Lee et al., 2014).  
Taken together, our data suggests that Runx1 functions to regulate scar deposition 
and degradation and to repress myocardial proliferation and differentiation as well as 
myocardial survival in the zebrafish heart. The fact that one gene can inhibit multiple aspects 
of heart regeneration offers the exciting prospect that all these processes can be targeted 
simultaneously in efforts to achieve human heart repair. Of note, small molecule drugs 
inhibiting Runx1 have already passed pre-clinical testing in the context of leukaemia treatment 
(Illendula et al., 2016). Even though the zebrafish is capable of regeneration, the runx1 mutant 
shows that this process may not be optimal, arising from the need to initiate a fibrotic response 
for immediate repair and to potentially to keep cardiomyocyte proliferation under control during 
myocardial regeneration. During evolution, adult zebrafish seem to have established a fine 
balance regulating fibrosis and myocardial proliferation without losing control of cell division; 
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understanding how this balance is maintained may open up novel targets for future therapeutic 





Zebrafish strains and husbandry 
All experiments were carried out under appropriate Home Office licenses and in compliance 
with the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU 
in Europe, and all have been approved by Oxford’s central Committee on Animal Care and 
Ethical Review (ACER). Adult wild-type (wt) (KCL strain), Tg(kdrl:Hsa.HRAS-mCherry)(Chi 
<i>et al.</i>, 2008) (Chi et al., 2008) and runx1W84X mutants (Jin et al., 2012), 
TgBAC(runx1P2:Citrine) (Bonkhofer et al., 2019)  were housed in a Techniplast aquarium 
system (28 °C, 14/10 hours light/dark cycle, fed 3x daily with dry food and brine shrimp). All 
double transgenic lines on wild-type or mutant background were generated by natural mating.  
 
Cardiac surgery 
All procedures/protocols were carried out in accordance with British Home Office regulations, 
with respective project licenses held in all contributing labs, approved by Home Office 
inspectors and local representatives. Zebrafish cryo-injury and resection injury of the ventricle 
were performed as previously reported (González-Rosa and Mercader, 2012; Koth et al., 
2017). Briefly, prior to all surgical operations, fish were anaesthetised in MS222 (Sigma). A 
small incision was made through the thorax and the pericardium using forceps and spring 
scissors. The abdomen was gently squeezed to expose the ventricle and tissue paper was 
used to dry the heart. A cryo-probe with a copper filament was cooled in liquid nitrogen and 
placed on the ventricle surface until thawing was observed. Body wall incisions were not 
sutured, and after surgery, fish were returned to water and stimulated to breathe by pipetting 
water over the gills until the fish started swimming again. For sham surgery, the thorax and 
pericardial sac were opened, and the heart was touched, but not injured. All operated fish 
were kept in individual tanks for the first week after surgery, then fish were combined in larger 
tanks. The surgeries were carried out at the same time during the day for all groups, and by 





Hearts were extracted and transferred to Ringer solution with heparin sodium salt (50 U/ml) 
(Ringer composition: 7.2 g NaCl, 0.225g CaCl2.H2O, 0.37g KCl, 0.2175g Na2HPO4.7H2O, 
0.02g KH2PO4 at pH 7.4 sterilised by using a 0.22um bottle top filter unit) and rinsed once with 
Phosphate buffered saline (PBS) or directly isolated in PBS. Hearts were inspected, cleaned 
and then fixed with 4% Paraformaldehyde (PFA) overnight (O/N) at room temperature (RT). 
Samples were rinsed once in PBS, dehydrated into Ethanol (EtOH) at 70%, 80%, 90%, 96% 
for 2 hours each step and 2x100% for 1 hour each step, followed by a 100% 1-butanol step 
overnight. The samples were then transferred to paraffin (Paraplast Plus, Sigma-Aldrich 
P3683) wax at 65°C. Paraffin was refreshed 2x with each step at least 2 hours, prior to 
mounting in a sectioning mould. 10 µm sections were cut using a Leica microtome and section 
ribbons were stored on black cardboard in shallow stackable plastic trays. Individual sections, 
evenly distributed throughout the heart e.g. 1 in 6 sections, were selected and mounted on 
superfrost plus glass slides for histology, histochemistry and RNA labeling (RNAscope).  
 
Histology 
For Acid Fuchsin Orange G-staining (AFOG), dewaxed and water rinsed sections were refixed 
in Bouin’s solution for 3h at 60°C and then washed in ddH2O until sections were white/clear, 
incubated in aquous 1% phospknowybdic acid for 5min, rinsed with ddH2O, stained with AFOG 
solution for 5 min, rinsed shortly in ddH2O, dehydrated quickly through 70%, 80%, 90%, 96% 
and 100% EtOH, cleared in Xylene and mounted in DPX mounting medium. AFOG solution: 
Boil 1l ddH2O with 5g of Methyl Blue (Sigma #95290), once cooled - add 10g Orange G (Sigma 






Fluorescent immunohistochemistry was performed as previously described (Mommersteeg et 
al., 2010). For de-waxing, slides were taken through 2x Xylene 5min, 2x 1min in 100% EtOH 
2 min, 1x 96%, 90%, 80% and 70% EtOH, and a final rinse in PBS-T prior to subsequent 
staining. De-waxed and rehydrated sections were heated up and then pressure cooked for 4 
minutes in antigen unmasking solution (H-3300, Vector Laboratories Inc). Once cooled, 
sections were placed in PBS before drawing a ring (ImmEdge pen, Vector Laboratories) 
around the sections. Slides were placed into staining trays providing humidity and blocked 
using TNB (0.5% TSA blocking reagent, 0.15 M NaCl, 0.1M TRIS-HCL, pH 7.5, 
NEL702001KT, Perkin Elmer) for 30min at RT. Blocking agent was removed and primary 
antibody in TNB was added and incubated O/N at RT. Slides were then washed 3x 5 min in 
PBS before the secondary antibody (Alexa range, Invitrogen) at 1:200 dilution in TNB was 
added for 2 hours at RT. For some primary antibodies, an additional amplification step was 
added to enhance the signal using the TSA kit (NEL756001KT, Perkin and Elmer). Instead of 
an Alexa secondary antibody, a biotinylated secondary antibody was used at 1:200 dilution in 
TNB for 45 min at RT, followed by 3x 5min washes in PBS-T prior to 30 min incubation with 
conjugated Streptavidin-Horse Radish Peroxidase (Vector Laboratories, SA-5004) and 
subsequent 3x 5 min washes in PBS-T. Then either Fluorescein or Tetramethylrhodamine (in 
DMSO) diluted at 1:100 in amplification buffer was added to the sections for 3 minutes, 
followed by 3x 5 min washes with PBS and staining with DAPI (2.5µg/ml, Sigma). Slides were 
mounted in Mowiol 4-88 (Applichem) and slides incubated at 37˚C O/N in the dark. The 
following primary antibodies were used: chicken polyclonal against Green Fluorescent Protein 
(GFP, 1:200, Aves Lab, GFP-1020), mouse monoclonal against mCherry (clone 1C51, 1:200, 
Abcam, ab125096), Proliferating Cell Nuclear Antigen (PCNA, clone PC10, 1:200, Dako 
Cytomation, M0879), Myosin Heavy Chain (MF20, 1:50, HSHB AB-2147781) and 
Plasminogen (Plg, 1:200, R&D systems, MAB1939). Rabbit polyclonal against Lysozyme 
(LyC, 1:200, Anaspec, AS-55633), ETS Transcription Factor ERG (ERG, 1:200, Abcam, 
ab110639), Myocyte Enhancer Factor 2 (Mef2 C-21, 1:200, Santa Cruz, sc-313), smooth 
muscle Myosin heavy chain 11 (Myh11, 1:200, Abcam, ab125884), Transgelin (SM22a, 1:200, 
24 
 
Abcam, ab14106) and Annexin A2 (Anxa2, 1:200, Invitrogen, PA5-14317). Most antibodies 
are commonly used for zebrafish research. Myh11 and Annexin A2 were validated by 
overlapping expression with the respective RNAscope probes. For double labelling with 
RNAscope probes, RNAscope was performed first and then processed for 
immunohistochemistry as described above, starting from the blocking step. Images were 
processed in ImageJ to generate magenta and green color combinations. 
 
RNAscope In Situ Hybridisation 
RNAscope® (Advanced Cell Diagnostics, Hayward, CA) (34) was performed on 10µm thick 
paraffin sections, processed as described above. Sections were baked at 60°C for one hour 
before deparaffinisation using 2x 5 min Xylene steps followed by 2x 2 minutes 10% EtOH. The 
slides were air-dried followed by incubation in RNAscope Hydrogen Peroxide (H202) for 15 
minutes before washing in MilliQ. The slides were then boiled at 98-102C for 15 minutes in 1x 
RNAscope® Target Retrieval solution, placed in 100% EtOH for 3 minutes and air-dried. The 
sections were the incubated with RNAScope Protease III in a Hybez oven at 40°C for 12 min, 
washed in MilliQ 2x 2 minutes, followed by incubation with the different RNAScope probes for 
2 hours at 40°C. The RNAscope Multiplex Fluorescent Detection Reagents v2 and the TSA 
Plus Cyanine 3 and 5 fluorophore (Perkin Elmer, NEL744001KT) were applied according to 
the manufactures instructions. The slides were further processed for immunohistochemistry 
or mounted in Mowiol 4-88. Advanced Cell Diagnostics designed the probes. Probes used 
were Dr-tcf21-C2 (485341-C2), Dr-itga2b-C2 (555601-C2), Dr-runx1 (433351), Dr-myb-C3 
(558291-C3), Dr-gata2b-C2 (551191-C2), Dr-anxa2a (587021) and Dr-serpine1 (551171-C3). 
 
Image acquisition and data analysis 
Images were acquired using either a Zeiss LSM880 or Olympus FV3000 confocal. Images 
were processed in FIJI/ ImageJ to generate a magenta/green/cyan/grey color scheme.  
For all quantifications on sections, individual sections were mounted, evenly distributed 
throughout the heart e.g. 1 in 6 sections, to reduce the number of hearts needed and 
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guarantee even coverage of the entire heart. Using Fiji/ image J, myocardial regeneration was 
then quantified by measuring the perimeter of the ventricle of each heart section of AFOG-
stained hearts and the length of open compact myocardium. The biggest open myocardium 
length and ventricle perimeter measurement from each fish was then taken and the open 
myocardium length was divided by the ventricle perimeter and multiplied by 100 to give the 
percentage of the myocardium that was still open. Wound area and ventricle area were also 
measured for each section (using Fiji/ image J) and again the biggest measurement of each 
for each fish was used to calculate the size of the wound region. This was done by dividing 
the wound area by the ventricle size, then multiplying by 100 to give a percentage. For analysis 
of the colour of the wound area on the sections stained with AFOG, we split the colour photo 
of the wound area up into a red, green and blue channel. The images were then thresholded 
using the same settings for all hearts for the red and blue channel. The orange area was 
determined by subtracting the red and blue areas from the total area. 
Myocardial proliferation was assessed by using Mef2, a nuclear myocardial marker, and 
proliferating cell nuclear antigen (PCNA), a nuclear marker of proliferation, on antibody stained 
sections. The border zone region was established as the cardiomyocytes closest to the wound 
in the healthy myocardial tissue. The number of Mef2+ nuclei was counted and the number of 
PCNA/ Mef2 double+ nuclei counted and their percentage calculated for at least 3 sections 
per fish. 
 
Heart processing for FACS 
Freshly isolated hearts were placed in chilled Hanks balanced buffered saline (HBBS), atria 
and bulbus arteriosus were removed and the ventricle was cut into several pieces using fine 
forceps and ophthalmic scissors (FST, 15009-08). The following digestion procedure was 
adapted from (Cao et al., 2015): Pieces were transferred to a 2 ml tube, rinsed with HBBS, 1 
ml (up to 10 hearts) of digestion mix (0.13 U/ml Liberase DH (Roche) and 1% sheep serum in 
HBBS) was added and incubated at 32°C and 80-100rpm rotation/agitation. Every 10-15 min 
supernatant was collected and placed on ice and new digestion mix was added and pieces 
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and solution where gently pipetted 5-10 times to aid break up. Once all tissue was resolved 
~1h all collected suspensions were spun at 300g for 10min, supernatant was removed and 
replaced with 1% fetal bovine serum in HBBS, suspensions were then combined and placed 
on ice. Prior to FACS (MoFlo Asterios, Beckman and Coulter) cells were stained with Dapi to 
gate for dead cells. 
 
Single cell sequencing 
Cells from 20 hearts per sample from isolated uninjured WT and 3 dpi injured WT and 
Runx1W84X/W84X ventricles were FACS sorted and populations of single and double positive 
cells were isolated separately. The single and double positive cells were then mixed, so that 
the samples were 1/3 Citrine positive, 1/3 double positive and 1/3 mCherry positive. Cells were 
washed in PBS with 0.04% BSA and re-suspended before loading 12,000-12,500 cells onto 
each channel of the Chromium 10x Genomics platform to capture single cells in droplets. 
Library generation for 10x Genomics v2 chemistry was performed following the Chromium 
Single Cell 3ʹ Reagents Kits User Guide: CG00052. Quantification of cDNA was performed 
using Qubit dsDNA HS Assay Kit (Life Technologies Q32851) and high-sensitivity DNA tape-
station (Agilent. 5067-5584). Quantification of library construction was performed using Qubit 
dsDNA HS Assay Kit (Life Technologies Q32851) and high-sensitivity DNA tape-station 
(Agilent. 5067-5584). Libraries were sequenced on Illumina HiSeq4000 platform to achieve a 




The count function in 10x Genomics Cellranger software (v2.1.1) was used for sample 
demultiplexing, barcodes processing and gene counting with --chemistry=threeprime. 
(https://support.10xgenomics.com/single-cell-gene-
expression/software/pipelines/latest/installation). The Danio_rerio.GRCz11 (release 94) 
version of Zebrafish genome and gene annotation files used for alignment were downloaded 
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from the Ensembl database. (ensembl.org) We added the sequences for the mCherry-plasmid 
and Citrine-plasmid. The mCherry-plasmid had three sequence contents: mCherry, the 
mCherry-plasmid-backbone and mCherry-polyA. The Citrine-plasmid had seven sequence 
contents: Citrine-3x-HA-tag, Citrine-BirA, Citrine-Tav-2a, Citrine, Citrine-polyA, Citrine-Frt1 
and the remaining plasmid backbone sequences (Citrine-Remaining). The new reference with 
the additional sequences was built using the mkgtf function in Cellranger. In order to eliminate 
potential reads that were aligned to both plasmids, only uniquely mappable reads were 
considered for STAR alignments with an additional parameter –‘outFilterMultimapNmax’, ‘1’, 
added in the reference.py file.  
 
Quality control 
Quality control was performed from the raw counts with all barcodes. Firstly, cells with less 
than 100 genes expressed were removed. 4720, 4754 and 6268 cells passed for the wild-type 
uninjured, wild-type 3dpci and runx1W84X/W84X 3dpci samples respectively. Secondly, doublets 
were filtered using the scrublet (58) package in Python. Cells with doublet score larger than 
0.3, 0.27 and 0.38 for the wild-type uninjured, wild-type 3dpci and runx1W84X/W84X 3dpci 
samples were removed respectively. This excluded 55 wild-type uninjured cells, 58 wild-type 
3dpci cells and 214 runx1W84X/W84X 3dpci cells. After quality control 4665 wild-type uninjured 
cells, 4696 wild-type 3dpci cells and 6054 runx1W84X/W84X 3dpci cells were retained. Mean 
reads per cell: 18082 for wild-type uninjured, 18652 for wild-type 3dpci and 13099 for 
runx1W84X/W84X 3dpci cells, with sequencing saturation ≥ 50%. Non-expressed genes were 
removed and cells were normalized to 10,000 for each cell and log-transformed.  
 
Defining cell-types based on marker genes 
mCherry positive (mChr+) cells were defined as a union of cells that have at least 1 unique 
molecular identifier (UMI) count in either mCherry, mCherry-plasmid-backbone or mCherry-
polyA. Citrine positive (Cit+) cells were defined as a union of cells that have at least 1 UMI in 
either citrine, citrine-polyA or citrine-remaining. If the cell had at least 1 UMI for kdrl/runx1 
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gene, then the cell was labelled as kdrl positive (kdrl+) or runx1 positive (runx1+). kdrl+mChr+ 
cells were defined as the cells that were either kdrl+ or mChr+. Runx1+cit+ cells were defined 
as the cells that are either runx1+ or cit+. Finally, the double positive (double+) cells were 
defined as cells that are both kdrl+mChr+ and runx1+cit+. The number of cells for each cell 
type is summarised in the table below: 
Cell Type WT Injured Injured Runx1 KO Total 
mChr+ 1429 (30.63%) 761 (16.21%) 1013 (16.73%) 3203 (20.78%) 
Cit+ 1178 (25.25%) 1644 (35.01%) 2472 (40.83%) 5294 (34.34%) 
Kdrl+ 903 (19.36%) 407 (8.67%) 454 (7.50%) 1764 (11.44%) 
Runx1+ 12 (0.26%) 26 (0.55%) 44 (0.73%) 82 (0.53%) 
Kdrl+mChr+ 1723 (36.93%) 934 (19.89%) 1208 (19.95%) 3865 (25.07%) 
Runx1+cit+ 1182 (25.34%) 1653 (35.20%) 2483 (41.01%) 5318 (34.50%) 
Double+ 99 (2.12%) 262 (5.58%) 200 (3.30%) 561 (3.64%) 
 
For extracting subsets of cells, including cardiomyocytes (255 cells), double+ cells (561 cells) 
and double+ without runx1W84X/W84X cells (361 cells), the same quality control pipeline was 
applied.  
 
Selection of highly variable genes 
Highly variable genes (HVGs) were selected following the Seurat (Butler et al., 2018) (method 
with parameters: min_mean=0.0125, max_mean=4 and min_disp=0.5. 4663, 2341, 3484 and 
3377. HVGs were selected for all cells, CMs, double+ cells and double+ without injured 
runx1W84X/W84X cells. Cells were then log-transformed. The effects of total number of counts 
and the percentage mitochondrial genes were regressed out and each gene was scaled so 
that it was zero-centred.  
 
Visualization and Clustering 
For UMAP visualisation (Uniform Manifold Approximation and Projection), firstly, a k=10 
nearest neighbour graph was calculated on the first 50 principle components of the PCA based 
on HVGs using the neighbours function in Scanpy (Wolf, Angerer and Theis, 2018). Then the 
UMAP was calculated based on this k-nearest-neighbour graph using the UMAP function in 
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Scanpy. The sub cell populations were determined by Louvain clustering with resolution 1, 
0.5, 0.6, 0.7 for all cells, cardiomyocytes, double+ cells and double+ without runx1W84X/W84X 
cells respectively. In total, 26 clusters were defined in all cells, 3 clusters for CMs and 5 
clusters for both double+ cells and double+ without runx1W84X/W84X cells. 
 
Differential expression and Gene Ontology Annotation 
Differential expression (DE) analysis was performed using rank_genes_groups in Scanpy with 
the ‘t-test_overestim_var’ method that overestimates variance of each group. The p values 
were corrected by the ‘benjamini-hochberg’ (BH) method to account for the multiple 
comparisons problem. Gene ontology (GO) information was downloaded from the ZFIN 
database. (https://zfin.org/downloads) Only GO terms with more than 5 genes and less than 
500 genes were considered. The enriched GO terms were calculated by a hypergeometric 
test on the top 50 genes using phyper function in R. Then the p values were then corrected 
by the ‘benjamini-hochberg’ (BH) method using p.adjust function in R. 
 
Data plotting 
The violin and heatmap plots were made using seaborn and matplotlib modules in Python, 
and the dotplots using the dotplot function in Scanpy. The dotplots of the epicardial and the 
myofibroblast clusters (Fig.8e.) were coloured by the scaled mean expression value by 
dividing its maximum. The size of dots indicates the number of cells expressing the selected 
genes for each group. This number was scaled by dividing its maximum. The dotplot of the 
CM cluster (Fig.9c.) was coloured by the scaled mean expression value for each group, 
calculated by subtracting the minimum and dividing each by its maximum. The dot size was 
represented as the fraction of cells expressing the selected genes. 
 
Statistical analysis 
The number of samples (n) used in each experiment is shown in the legends and recorded in 
detail below. Appropriate sample sizes were computed when the study was being designed 
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and no data was excluded. ANOVA tests were applied when normality and equal variance 
tests were passed. Surgeries were not randomised, but during analysis, measurements and 
counts were performed blinded. Animals of the same age were used within experiments and 
as controls. Animals were not selected for sex. Results are expressed as mean ± SEM. (* for 
P < 0.05, ** for P< 0.01, *** for P< 0.001 and **** for P<0.0001). Statistical analysis was 
performed in GraphPad Prism 6 for Windows, GraphPad Software, La Jolla California USA, 
www.graphpad.com. 
Fig. 2f. Two-way ANOVA with Sidak test, all time points n=5 wild-types, n=5 runx1 mutants. 
Comparing wild-type versus mutant per time point. 3dpci p=0.1951, 7dpci p=0.9486, 14dpci 
p=0.0034, 30dpci p>0.9999, 70dpci p=0.9973. 
Fig. 2g. Two-way ANOVA with Sidak test, all time points n=5 wild-types, n=5 runx1 mutants. 
Comparing wild-type versus mutant per time point. 3dpci p=0.0222, 7dpci p=0.7108, 14dpci 
p=0.1220, 30dpci p>0.3548, 70dpci p=0.7223. 
Fig. 2i-k. Two-way ANOVA with Sidak test, n=5 wild-types, n=5 runx1 mutants. Orange 
p=0.0001, red p=0.0220, blue p=0.1312. 
Fig. 3e. Two-way ANOVA with Sidak test. Uninjured, sham, 1dpci and 14dpi n=4. 3 and 7dpci 
n=5. Comparing time points within wound or ventricle. All ventricle comparisons p>0.9999. 
Wound: uninjured vs sham p=0.9954, uninjured vs 1dpci p=0.0025, uninjured vs 3dpci 
p=0.0005, uninjured vs 7dpci p=0.0970, uninjured vs 14dpci p>0.9999, sham vs 1dpci 
p=0.0501, sham vs 3dpci p=0.0144, sham vs 7dpci p=0.7469, sham vs 14dpci p>0.9999, 
1dpci vs 3dpci p>0.9999, 1dpci vs 7dpci p=0.8847, 1dpci vs 14dpci p=0.0118, 3dpci vs 7dpci 
p=0.6164, 3dpci vs 14dpci 0.0029, 7dpci vs 14dpci p=0.3351. 
Fig. 6d. Unpaired, two-tailed, equal variance t-test. n=5 wild-types, n=5 runx1 mutants, 
p=0,0239. 
Fig. 10c. Two-way ANOVA with Sidak test, all time points n=5 wild-types, n=5 runx1 mutants. 
3dpci p=0.0002, 7dcpi p=0.0095, 14dpci p=0.0452. 
Fig. 10e. Two-way ANOVA with Sidak test, all time points n=5 wild-types, n=5 runx1 mutants. 
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Figure 1. Runx1-Citrine becomes strongly expressed in the heart after cryo-injury.  
a-d”, immunohistochemistry for Runx1-Citrine (GFP antibody) and myocardial marker MF20 
at different time points after cryo-injury. a-a’, Citrine expression in the uninjured hearts was 
confined to a small number of cells scattered around the heart (arrowheads). b-b”, at 1 dpci 
the epicardium was Citrine-positive (arrowheads), as well as bright blood cells within the 
wound and dim expression of Citrine overlapping with MF20 (b”). c-c”, at 3 dpci, the 
epicardium, endocardium (arrowheads) and other wound cells were positive for Citrine. Also 
the myocardium in the border zone next to the wound was highly Citrine-positive (c”). d-d”, 
expression of Citrine diminishes at 14 dpci. But expression is still visible, especially in the 
myocardium (d”). e-e’, in situ hybridisation for itga2b with immunohistochemistry for Runx1-
Citrine and nuclear marker Dapi. Arrowheads point to overlap of Runx1-Citrine with itga2b 
mRNA indicating that thrombocytes are positive for Runx1-Citrine. a, atrium; ba, bulbus 
arteriosus; dpci, days post cryo-injury; en, endocardium; ep, epicardium; v, ventricle; w, 
wound. Scale bars 100 μm. 
 
Figure 2. Different wound composition and faster regeneration in runx1 mutant 
compared to wild-type hearts.  
a-e, AFOG staining of wild-type and runx1 mutant ventricles at 5 different time points after 
injury. f-g, quantification of the difference in wound size between the wild-type and mutant at 
the different time points, measured by percentage of the compact wall not yet closed (f) and 
the % of wound area compared to total ventricle area (g). n=5 per time point, two-way ANOVA 
with Sidak test. h-i, quantification of differences in wound composition between the fish at 
7dpci (collagen – blue; fibrin - bright red; all other  cells including myocardium/blood cells - 
orange), n=5. c, collagen; f, fibrin; v, ventricle; w, wound. Scale bars 100 μm. 
 
Figure 3. Increased myocardial proliferation and protection in the runx1 mutant. 
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a-a’’, Immunohistochemistry for PCNA and Mef2 on 3dpci sections. An increased number of 
double positive cells (arrowheads) seem present in the mutant compared to the wild-type 
wound border. b, quantification of PCNA-positive proliferating Mef2-positive myocardial cells 
after injury shows increased myocardial proliferation in the runx1 mutant at all time-points 
analysed. n≥4, two-way ANOVA with Sidak test. c, Immunohistochemistry for MF20 with 
nuclear marker Dapi. Arrowheads point to presence of MF20-positive myocardial cells in the 
wound in the mutant at both 3 and 7 dpci. d, quantification of the MF20-positive area on in the 
wound on sections between the wild-type and mutant shows increased presence of 
myocardial cells in the mutant. n=5, two-way ANOVA with Sidak test. e, Immunohistochemistry 
for Citrine and MF20. Arrowheads point to the surviving MF20-positive cells in the mutant 
wound that are Runx1-Citrine negative. v, ventricle; w, wound. Scale bars depict 100 µm. 
 
Figure 4. Runx1-Citrine positive endocardial cells appear in the wound after injury. 
a-g, immunohistochemistry analysis for Citrine and mCherry positive cells in the Tg(BAC-
runx1P2:Citrine;kdrl:Hsa.HRAS-mCherry) line. a-a’, shows the wound at 1dpci, with the box 
highlighting the flat and weakly Citrine positive mCherry-positive endocardial cells in the 
wound. b-c, show well visible and round Citrine-mCherry positive cells in the wound at 3dpci 
(b-b’), but not further away from the wound (c-c’). d-d’, at 14dpci not many double positive 
cells are visible anymore. e, quantification of the number of Citrine-mCherry double positive 
cells in and away from the wound, n4, two-way ANOVA with Tukey’s test. f-g, runx1 mutant 
wounds have a reduced number of double positive cells. en, endocardium; v, ventricle; w, 
wound. Scale bars 100 μm. 
 
Figure 5. Single cell sequencing of Citrine and mCherry positive cells. 
a, experimental design of selection of cells for single cell sequencing using the 10x Genomics 
platform. b, UMAP plot of all cells combined, clustering into 27 different clusters. c, annotation 
of the different cell clusters. d, UMAP plot separated into citrine/runx1-positive cells, 
mcherry/kdrl-positive cells and double positive cells. e, UMAP plot separated into wild-type 
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uninjured cells, wild-type 3dpci cells and runx1 mutant 3dpci cells. Arrowheads point to the 
shift in endocardial/endothelial cells, with C0 and C2 appearing and C3 reducing in size after 
injury. HSC, haematopoietic stem cells, mt, mitochondrial. 
 
Figure 6. Subset of wild-type double positive cells expresses smooth muscle genes. 
a-b, all wild-type uninjured and 3dpci Tg(BAC-runx1P2:Citrine;kdrl:Hsa.HRASmCherry) 
double positive cells visualised in an UMAP plot. a, expression of collagen 1a1b specifically 
in 3dpci double positive cells. b, cell clustering within the double positive population identifies 
6 different cell clusters. c, heatmap showing that both cluster 4 and 5 express high levels of 
collagens, whereas cluster 4 specifically expresses smooth muscle genes. d, myh11a and 
tagln are expressed in cluster 4 after injury. Arrowhead points to myh11a expression in cell 
cluster 4. e-f, immunohistochemistry for Citrine, mCherry and Myh11. Arrowheads point to 
expression of Myh11 in Tg(BAC-runx1P2:Citrine;kdrl:Hsa.HRAS-mCherry) double positive 
cells at 3 (e-e’) and 7 dpci (f). en, endocardium; v, ventricle; w, wound. Scale bars 100 μm. 
 
Figure 7. Endocardial and thrombocyte Myh11-positive populations are strongly 
reduced in the runx1 mutant.  
a, UMAP plot of Tg(BAC-runx1P2:Citrine;kdrl:Hsa.HRASmCherry) double positive cells in the 
3dpci runx1 mutant as well as uninjured and 3dpci wild-type cells. Arrowheads point to the 
double positive cluster 4 that is absent in the runx1 mutant. b, violin plot showing that the 
absent cluster 4 is the cluster most strongly expressing smooth muscle genes in the wild-type 
after injury. c, immunohistochemistry for Citrine, Myh11 and MF20 showing reduced staining 
for Myh11 in the runx1 mutant wound at 7dcpi compared to the wild-type. Arrowheads point 
to overlap of Myh11 with Citrine in the endocardium. d, quantification of the area of Myh11 
expression in the wound on sections between mutants and wild-types. n=5, unpaired two-
tailed t-test. e-e’, in situ hybridisation for itga2b combined with immunohistochemistry for 
Citrine and Myh11 with nuclear marker Dapi. Arrowheads point to Myh11 expressing blood 
cells that express thrombocyte marker itga2b. f-g, UMAP plot of all cells confirms expression 
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of myh11a in the itga2b-positive thrombocyte cluster. v, ventricle; w, wound. Scale bars 100 
μm. 
 
Figure 8. Myh11-positive endocardial cells and thrombocytes retain their double 
identity. 
a-b’, in situ hybridisation for itga2b combined with immunohistochemistry for Citrine and 
Myh11. Arrowheads point to Myh11-positive itga2b-positive thrombocytes present in the wild-
type wound, that are largely missing in the runx1 mutant wound at 7dpci. c-d’, in situ 
hybridisation for itga2b combined with immunohistochemistry for Myh11 with nuclear Dapi 
staining. Both the endocardium (insert) and thrombocytes (arrowheads) still express Myh11 
in the wild-type wound at 14dpci, while absent in the mutant wound. v, ventricle; w, wound. 
Scale bars 100 μm.  
 
Figure 9. Reduction in myofibroblast numbers in the runx1 mutant. 
a, UMAP plot combining cluster 8 and 10 from Figure 4b, showing very few cells in these 
clusters in the uninjured wild-type, but appearance of both populations after injury in the wild-
type and runx1 mutant. b, UMAP plot from a, indicating expression levels of tcf21, myh11a, 
tagln and col1a1b. The epicardial cluster 8 expresses tcf21, whereas myofibroblast cluster 10 
expresses myh11a. Both cluster express tagln and col1a1b. c, staining of 7dpci sections 
confirms presence of Tagln and absence of Myh11 in the epicardium. d, single cell data 
showing numbers of cells per cluster per sample. Increased number of epicardial cells and a 
reduced number of myofibroblast cells in the runx1 mutant compared the wild-type. e, dotplot 
showing expression levels of smooth muscle, EMT and collagen genes per sample in cluster 
8 and 10. Increased cell numbers and expression of myofibroblast genes in both the epicardial 
and myofibroblast clusters in the injured wild-types compared to the uninjured wild-types. 
Epicardial myofibroblast gene expression is lower in the runx1 mutant compared to the 
uninjured wild-type, while the number of myofibroblast cells is strongly reduced in the mutant. 
f-g, Immunohistochemistry for Citrine and Myh11 on 7dpci sections. Analysis of Myh11 on 
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7dpci sections confirmed the reduction in myofibroblast cell numbers close to the epicardium 
(arrowheads). ep, epicardium; ventricle; w, wound. Scale bars 100 μm. 
 
Figure 10. Runx1 mutant hearts upregulate Anxa2 and Plasminogen. 
a, violin plots showing upregulation of anx2a and s100a10b in wild-type 
runx1/citrine;mcherry/kdrl double positive cells after injury, with even higher expression in the 
runx1 mutant. In contrast, serpine1 is down regulated in the mutant cells. b, UMAP plot of the 
runx1/citrine;mcherry/kdrl double positive cells showing thbs1b expressing cells. Arrowheads 
point to thbs1b expression mainly in cluster 4 from Fig. 6a, which is missing in the runx1 
mutant after injury. c, dotplot showing that anxa2a, calm1b, calm2b and calm3a are 
upregulated in the mutant citrine-positive myocardium at 3dpci, whereas sarcomere genes are 
upregulated in the wild-type citrine-positive myocardium. d-e’, section in situ hybridisation for 
anxa2a and serpine1 with immunohistochemistry for MF20 shows that anxa2a has a similar 
expression pattern as Runx1-Citrine after injury in the wild-type, but is much higher expressed 
in the mutant endocardium (white arrowheads) and myocardium (yellow arrowheads). 
Serpine1 expression is found in both the wound border endocardium (white arrowheads) and 
myocardium (yellow arrowheads). Sarcomere structure is different between the wild-type and 
the mutant in the wound border (d’’-e’’, blue arrowheads). f-g’, immunohistochemistry for 
Plasminogen and Anxa2 shows upregulation of Plasminogen in the area where Anxa2 is 
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Supp Figure 1. Runx1-Citrine becomes strongly expressed in the heart after cryo-injury.  
a-b’’, immunohistochemistry for Runx1-Citrine (GFP antibody) and myocardial marker MF20 
at 7dpci as well as in the sham heart. a-a’, at 7 dpci, the epicardium, endocardium and other 
wound cells were positive for Citrine. Also the myocardium in the border zone next to the 
wound was highly Citrine-positive (a’’). b-b’’, touching the heart with the probe without freezing 
cells and isolating the heart 3 days later (days post sham, dps) also initiates a response, with 
Citrine expression in the epicardium and myocardium. c-e, immunohistochemistry for Citrine, 
LyC, ERG1 and in situ hybridisation for tcf21. Arrowheads point to overlap of Runx1-Citrine 
with leukocyte marker lyC at 1dpci (c), and with endocardial marker ERG1 (d) and epicardial 
marker tcf21 at 3dpci (e). a, atrium; ba, bulbus arteriosus; ep, epicardium; v, ventricle; w, 




Supp Figure 2. Runx1-Citrine expression recapitulates endogenous runx1 expression.  
a-c, immunohistochemistry for Citrine combined with in situ hybridisation for runx1 showing 
overlap of Runx1-Citrine with runx1 mRNA in wild-type hearts. a, arrowheads point to double 
positive cells in the epicardium. b, arrowheads point to double positive cells in the myocardium, 
where the yellow asterisks point to double negative myocardium. c, arrowheads point to 

















Supp Figure 3. No significant differences in myocardial proliferation and regeneration 
after resection injury. 
a, AFOG staining of wild-type and runx1 mutant ventricles at 7dpa. b, immunohistochemistry 
for Runx1-Citrine and MF20 at different time points after resection-injury shows a similar 
pattern as seen after cryo-injury.  d, Immunohistochemistry for PCNA and Mef2 on 7dpa (days 
post amputation) sections. e, quantification of PCNA-positive proliferating Mef2-positive 
myocardial cells after injury points to no significant differences between the runx1 mutants and 











Supp Figure 4. Reduced number of Citrine-positive endocardial cells in the runx1 
mutant.  
a, immunohistochemistry for Citrine at 3dpci. Similar expression of the Runx1-Citrine protein 
between wild-type and runx1 mutant hearts after injury. b, FACS sorting for Runx1-Citrine and 
kdrl-mCherry shows an increase in double positive cells after injury in the wild-type compared 
to the uninjured wild-type hearts, whereas there is a reduction in the number of double positive 
cells in the injured runx1 mutant compared to the injured wild-types. v, ventricle; w, wound. 
















Supp Figure 5. Serpine1 expression overlaps with Runx1-Citrine after injury.  
a, heatmap showing example genes used to determine the identity of the different cell clusters. 
B, UMAP plot of all cells showing expression of serpine1. c-c’, immunohistochemistry for 
Citrine and mCherry combined with in situ hybridisation for serpine1. Analysis of serpine1 on 
3dpci sections shows a largely overlapping expression pattern to Runx1-Citrine in the 
endocardium (arrowheads and insert c’). d, UMAP plot of all cells show that runx1 mutant 
specific blood cell populations have high levels of expression of gata2b and myb. e-h’, 
immunohistochemistry for MF20 combined with in situ hybridisation for gata2b and myb. 
Inserts and arrowheads point to runx1 mutant specific gata2b and myb expression in blood 






Supp Figure 6. Upregulation of extracellular matrix genes in the runx1-citrine positive 
endocardium after injury.  
a, GO term analysis shows strong upregulation of GO terms associated with extracellular 
matrix formation in cluster 4 and 5 of the citrine/runx1;mcherry/kdrl positive cells after injury. 
b, immunohistochemistry for Myh11 combined with in situ hybridisation for myh11a and 
nuclear marker Dapi. Arrowhead points to overlap of myh11a mRNA with Myh11 protein, 
indicating specific binding of the Myh11 antibody.  w, wound. Scale bars depict 100 µm. 
 
 
 
 
